2024
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support
Radford M, Estcourt L, Sirotich E, Pitre T, Britto J, Watson M, Brunskill S, Fergusson D, Dorée C, Arnold D. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support. 2024, 2024: cd011305. PMID: 38780066, PMCID: PMC11112982, DOI: 10.1002/14651858.cd011305.pub3.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnemiaBiasChildErythrocyte TransfusionHematologic NeoplasmsHematopoietic Stem Cell TransplantationHemoglobin AHemoglobinsHumansNon-Randomized Controlled Trials as TopicQuality of LifeRandomized Controlled Trials as TopicConceptsRed blood cell transfusion strategyHaematopoietic stem cell transplantationLiberal transfusion strategyClinically significant bleedingRestrictive transfusion strategyNon-randomised studiesTransfusion strategyIntensive chemotherapyRandomised controlled trialsRed blood cellsSignificant bleedingAll-cause mortalityLength of hospital admissionAcute leukemiaHaematological malignanciesRisk of clinically significant bleedingHaematopoietic stem cell supportProspective non-randomised studyRisk ratioControlled trialsQuality of lifeStem cell supportStem cell transplantationMalignant haematological disordersCochrane Central Register of Controlled Trials
2020
Cluster‐randomized trials in transfusion medicine
Sirotich E, Barty R, Li N, Arnold D. Cluster‐randomized trials in transfusion medicine. Transfusion 2020, 60: 2470-2473. PMID: 32969498, DOI: 10.1111/trf.16090.Peer-Reviewed Original Research